Determination of High Sensitivity C-Reactive Protein in Metabolic Syndrome | Chapter 12 | New Frontiers in Medicine and Medical Research Vol. 5
Background: If a person has metabolic syndrome, their risk
of cardiovascular disease and type 2 diabetes mellitus is greatly elevated. In
India, obesity and type 2 diabetes have become epidemics. Low-grade systemic
inflammation characterises metabolic syndrome, which is a pro-inflammatory
disease. C-reactive protein (CRP), a biomarker, is a reliable sign of chronic
systemic inflammation. Higher levels of high sensitivity C-reactive protein
(Hs-crp) have been associated to metabolic syndrome and its components, and can
help predict future cardiovascular events. The following are the goals of the
research: 1) The link between metabolic syndrome and high-sensitivity C
reactive protein 2)An investigation of high-sensitivity C reactive protein as a
surrogate measure of chronic inflammation in the metabolic syndrome. Methods
and Materials The participants in this cross-sectional study included 50
patients with metabolic syndrome aged 18 and up, as well as 50 age and sex
matched controls who came to the OPD or were admitted to the Bangalore Medical
College medical department wards. Using the new IDF criteria, metabolic
syndrome was identified. A fasting blood sample was obtained to determine the
levels of hs-CRP, blood glucose, and lipid profile. The waist circumference,
height, and weight were all the same. The values of several demographic
characteristics such as BMI, waist circumference, blood pressure, and
biochemical parameters such as blood sugar and lipid profile between cases and
controls were statistically significant. With a p value of 0.001, patients with
metabolic syndrome had a higher mean value of hs-CRP (8.31.04 vs 1.60.79mg/l). Conclusion:
Patients with metabolic syndrome had significantly higher levels of hs-CRP when
compared to controls, and hs-CRP levels grew linearly with the number of
metabolic syndrome components. As a result, hs-CRP can most likely be used as a
surrogate marker of chronic inflammation in patients with metabolic syndrome.
Author(s) Details
Department of Medicine, Bangalore Medical College and Research Institute, Bangalore, India.
Dr. T. R. Mamatha
Department of Medicine, Bangalore Medical College and Research Institute, Bangalore, India.
Dyaneshwar Nirgude
Department of Medicine, Bangalore Medical College and Research Institute, Bangalore, India.
Irinel Popescu
Prakash Basappa Hosamani
Department of Medicine, Bangalore Medical College and Research Institute, Bangalore, India.
View Book :- https://stm.bookpi.org/NFMMR-V5/article/view/3028
Comments
Post a Comment